ESBATECH A NOVARTIS CO LLC has a total of 100 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in Japan, Republic of Korea and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ARCH ONCOLOGY INC, VIELA BIO INC and ESBATECH - A NOVARTIS CO LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 34 | |
#2 | Republic of Korea | 20 | |
#3 | China | 7 | |
#4 | EPO (European Patent Office) | 7 | |
#5 | Australia | 6 | |
#6 | Hong Kong | 4 | |
#7 | United States | 4 | |
#8 | WIPO (World Intellectual Property Organization) | 4 | |
#9 | Mexico | 3 | |
#10 | Canada | 2 | |
#11 | Chile | 2 | |
#12 | Serbia | 2 | |
#13 | Argentina | 1 | |
#14 | Brazil | 1 | |
#15 | Colombia | 1 | |
#16 | Hungary | 1 | |
#17 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Machines | |
#6 | Computer technology | |
#7 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Sugars | |
#7 | Compounding processes | |
#8 | Bioinformatics | |
#9 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Urech David | 37 |
#2 | Borras Leonardo | 35 |
#3 | David Urech | 23 |
#4 | Escher Dominik | 21 |
#5 | Leonardo Borras | 19 |
#6 | Barberis Alcide | 14 |
#7 | Auf Der Maur Adrian | 14 |
#8 | Ewert Stefan | 12 |
#9 | Sommavilla Roberto | 9 |
#10 | Riegler Astrid C | 9 |
Publication | Filing date | Title |
---|---|---|
AU2016277637A1 | Stable and soluble antibodies | |
CA2896174A1 | Acceptor framework for cdr grafting | |
AU2013378628A1 | Acceptor framework for CDR grafting | |
EP2809344A1 | Antibody-containing sustained-release formulation for ocular administration | |
MX2014004521A | Stable multiple antigen-binding antibody. | |
HUE036125T2 | Stable and soluble antibodies | |
RS56862B1 | Stable and soluble antibodies | |
AU2013203189A1 | Stable and soluble antibodies | |
KR20180005752A | Methods for identifying immunobinders of cell-surface antigens | |
KR20180097792A | STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |